Skip to content
★ Sign in to follow
JT

John Talley V

Immune Pharmaceuticals Inc
Total declarations
3
Company
1
▲ Purchases (3 ops.)
€26k
▼ Sales (0 ops.)
—

Latest filing published 13 Dec 2007 for IMMUNE PHARMACEUTICALS INC, €14k.

Insider track record

Disclosed buys
3
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
3

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

John Talley V: trading record in brief

This profile gathers the share dealings of John Talley V in Immune Pharmaceuticals Inc. Over a trading history stretching from 28 August 2007 to 13 December 2007, the count stands at 3 filings.

Purchases make up the whole of the open-market record (3 purchases, €26k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.

Half of the purchases are above €11k and half below.

On 13 December 2007 came the latest disclosure, an open-market purchase for €14k in Immune Pharmaceuticals Inc. Publication is fast: at least half of the trades appear on SEC (Form 4) on the same day. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to John Talley V

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations3 total
  • ▲
    President, CEO & DirectorExecutivesImmune Pharmaceuticals Inc
    21,000 USD0SEC
    15,000 shares@ US$1.40Common Stock, par value $0.0001SEC:0000909518-07-001069:0
    Canonical exit: 12 Mar 2008 (T+90)
  • ▲
    President, CEO & DirectorExecutivesImmune Pharmaceuticals Inc
    1,804 USD0SEC
    1,100 shares@ US$1.64Common Stock, par value $0.0001SEC:0000909518-07-000789:0
    Canonical exit: 26 Nov 2007 (T+90)
  • ▲
    President, CEO & DirectorExecutivesImmune Pharmaceuticals Inc
    14,685 USD0SEC
    8,900 shares@ US$1.65Common Stock, par value $0.0001SEC:0000909518-07-000789:1
    Canonical exit: 26 Nov 2007 (T+90)

3 of 3 declarations